IL1A and cancer: Accordingly, IL-1α deletion delayed cancer progression in a mouse model of pancreatic cancer; in this model, a decrease in the number and grade of PanIN (Pancreatic Intraepithelial Neoplasia) lesions was observed in IL-1α-null mice compared to their WT counterparts (88).